Drug discovery is a long process, often taking over 10 years to find the right targets
PROBLEM
Lacking data and targets?
The industry’s biggest challenge is that it is difficult to obtain enough usable and actionable data that results in novel drug targets. This makes even the best organisations fall behind the competition.
10+
Years
Unusable
Data
Data is not standardised and is difficult to access
Limited
Insights
Analysis is often limited to pre-configured tools
Unverifiable
Insights
Difficult to verify targets without clinical records
Only with the right data, you avoid going from…

SOLUTION
Connect to the world’s unused data to obtain novel therapeutic insights
We believe that all data that can be used to cure diseases, should be used.
150+
Biobanks and Population Genomics initiatives making their biomedical data available
10M+
Datasets within our network,
ranging from cancer to rare diseases
100M+
Real World Evidence data points
in our real time learning knowledge graph
TESTIMONIAL
By sharing their wealth of expertise in genomics and biodata science, and empowering our scientists with the technology and skills to leap forward our research, Lifebit demonstrated it is the industry leader providing true end-to-end solutions that embrace all community standards.


Dr. Anne Deslattes Mays
Principal Computational Scientist
Principal Computational Scientist